The hidden coagulation risk in plasma-derived biologics
Explore how specialist hemostatic risk testing can prevent costly clinical failures in plasma-derived biologics
Explore how specialist hemostatic risk testing can prevent costly clinical failures in plasma-derived biologics
From smarter data capture to predictive analysis, next‑generation R&D data platforms are streamlining complexity and accelerating decision‑making across the lab
Eisai enters into collaborative research agreement with University of Dundee
Agilent ZORBAX 300Å StableBond columns are an ideal choice for the reproducible separations of proteins and peptides.
Initial twelve-month collaboration successfully identifies hit compounds and progresses into hit-to-lead optimization phase
Casgevy™ and Lyfgenia™ approvals pave the way for personalized gene editing therapies in treating sickle cell disease
First glimpse of next-generation solution for endotoxin detection at PDA 2018